Literature DB >> 12610126

Measles virus infects and suppresses proliferation of T lymphocytes from transgenic mice bearing human signaling lymphocytic activation molecule.

Bumsuk Hahm1, Nathalie Arbour, Denise Naniche, Dirk Homann, Marianne Manchester, Michael B A Oldstone.   

Abstract

Humans are the only natural reservoir of measles virus (MV), one of the most contagious viruses known. MV infection and the profound immunosuppression it causes are currently responsible for nearly one million deaths annually. Human signaling lymphocytic activation molecule (hSLAM) was identified as a receptor for wild-type MV as well as for MV strains prepared as vaccines. To better evaluate the role of hSLAM in MV pathogenesis and MV-induced immunosuppression, we created transgenic (tg) mice that expressed the hSLAM molecule under the control of the lck proximal promoter. hSLAM was expressed on CD4(+) and CD8(+) T cells in the blood and spleen and also on CD4(+), CD8(+), CD4(+) CD8(+), and CD4(-) CD8(-) thymocytes. Wild-type MV, after limited passage on B95-8 marmoset B cells, and the Edmonston laboratory strain of MV infected hSLAM-expressing cells. There was a direct correlation between the amount of hSLAM expressed on the cells' surface and the degree of viral infection. Additionally, MV infection induced downregulation of receptor hSLAM and inhibited cell division and proliferation of hSLAM(+) but not hSLAM(-) T cells. Therefore, these tg mice provide the opportunity for analyzing and comparing MV-T cell interactions and MV pathogenesis in cells expressing only the hSLAM MV receptor with those of tg mice whose T cells selectively express another MV receptor, CD46.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12610126      PMCID: PMC149525          DOI: 10.1128/jvi.77.6.3505-3515.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Proteolytic cleavage of the fusion protein but not membrane fusion is required for measles virus-induced immunosuppression in vitro.

Authors:  A Weidmann; A Maisner; W Garten; M Seufert; V ter Meulen; S Schneider-Schaulies
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor.

Authors:  N Ono; H Tatsuo; K Tanaka; H Minagawa; Y Yanagi
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Progression of T cell lineage restriction in the earliest subpopulation of murine adult thymus visualized by the expression of lck proximal promoter activity.

Authors:  C Shimizu; H Kawamoto; M Yamashita; M Kimura; E Kondou; Y Kaneko; S Okada; T Tokuhisa; M Yokoyama; M Taniguchi; Y Katsura; T Nakayama
Journal:  Int Immunol       Date:  2001-01       Impact factor: 4.823

4.  SLAM (CDw150) is a cellular receptor for measles virus.

Authors:  H Tatsuo; N Ono; K Tanaka; Y Yanagi
Journal:  Nature       Date:  2000-08-24       Impact factor: 49.962

5.  Signaling lymphocytic activation molecule (SLAM) is differentially expressed in human Th1 and Th2 cells.

Authors:  H Hamalainen; S Meissner; R Lahesmaa
Journal:  J Immunol Methods       Date:  2000-08-28       Impact factor: 2.303

6.  CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus.

Authors:  E C Hsu; C Iorio; F Sarangi; A A Khine; C D Richardson
Journal:  Virology       Date:  2001-01-05       Impact factor: 3.616

7.  Selective in vivo suppression of T lymphocyte responses in experimental measles virus infection.

Authors:  S Niewiesk; M Götzelmann; V ter Meulen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

8.  Clinical isolates of measles virus use CD46 as a cellular receptor.

Authors:  M Manchester; D S Eto; A Valsamakis; P B Liton; R Fernandez-Muñoz; P A Rota; W J Bellini; D N Forthal; M B Oldstone
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

9.  Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor.

Authors:  N Ono; H Tatsuo; Y Hidaka; T Aoki; H Minagawa; Y Yanagi
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

10.  Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells.

Authors:  I Fugier-Vivier; C Servet-Delprat; P Rivailler; M C Rissoan; Y J Liu; C Rabourdin-Combe
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

View more
  20 in total

1.  Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model.

Authors:  Sompong Vongpunsawad; Numan Oezgun; Werner Braun; Roberto Cattaneo
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

2.  Oncolytic measles virus retargeting by ligand display.

Authors:  Pavlos Msaouel; Ianko D Iankov; Cory Allen; Stephen J Russell; Evanthia Galanis
Journal:  Methods Mol Biol       Date:  2012

3.  Sphingosine kinase 1 regulates measles virus replication.

Authors:  Madhuvanthi Vijayan; Young-Jin Seo; Curtis John Pritzl; Sarah Angela Squires; Stephen Alexander; Bumsuk Hahm
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

4.  Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.

Authors:  Man Ki Song; Christofer J Vindurampulle; Alejandra V E Capozzo; Jeffrey Ulmer; John M Polo; Marcela F Pasetti; Eileen M Barry; Myron M Levine
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 5.  The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.

Authors:  Russell Maxwell; Andrew S Luksik; Tomas Garzon-Muvdi; Michael Lim
Journal:  Curr Neurol Neurosci Rep       Date:  2017-06       Impact factor: 5.081

6.  High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice.

Authors:  Caroline I Sellin; Nathalie Davoust; Vanessa Guillaume; Dominique Baas; Marie-Françoise Belin; Robin Buckland; T Fabian Wild; Branka Horvat
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Measles virus-induced immunosuppression in SLAM knock-in mice.

Authors:  Ritsuko Koga; Shinji Ohno; Satoshi Ikegame; Yusuke Yanagi
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

8.  Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity.

Authors:  Cory Allen; Georgia Paraskevakou; Ianko Iankov; Caterina Giannini; Mark Schroeder; Jann Sarkaria; Mark Schroeder; Raj K Puri; Stephen J Russell; Evanthia Galanis
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

9.  Measles virus interacts with human SLAM receptor on dendritic cells to cause immunosuppression.

Authors:  Bumsuk Hahm; Nathalie Arbour; Michael B A Oldstone
Journal:  Virology       Date:  2004-06-01       Impact factor: 3.616

10.  Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system.

Authors:  Veronika von Messling; Dragana Milosevic; Roberto Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.